Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2019 Nov 19;8(22):e013352.
doi: 10.1161/JAHA.119.013352. Epub 2019 Nov 7.

Transcatheter Mitral Valve Replacement in the Transcatheter Aortic Valve Replacement Era

Luca Testa  1 , Antonio Popolo Rubbio  1 , Matteo Casenghi  1 , Gaetano Pero  1 , Azeem Latib  2 , Francesco Bedogni  1
Affiliations
Review

Transcatheter Mitral Valve Replacement in the Transcatheter Aortic Valve Replacement Era

Luca Testa et al. J Am Heart Assoc. .
No abstract available

Keywords: aortic valve stenosis; mitral regurgitation; transcatheter aortic valve implantation.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Current transcatheter aortic valve replacement devices. A, Edwards SAPIEN XT (Edwards Lifesciences Inc). B, Edwards SAPIEN 3 (Edwards Lifesciences Inc). C, CoreValve Evolut R (Medtronic Inc). D, CoreValve Evolut PRO (Medtronic Inc). E, Acurate NEO (Boston, Marlborough). F, Acurate TA (Boston, Marlborough). G, Portico (Abbott). H, Biovalve (Biotronik). I, Centera (Edwards Lifesciences Inc). J, Direct Flow (Direct Flow Medical Inc), not commercially available. K, Lotus (Boston), not commercially available. There was recent US Food and Drug Administration approval for the new Lotus Edge.
Figure 2
Figure 2
Current transcatheter mitral valve replacement devices. A, CardiAQ/EVOQUE (Edwards Lifesciences Inc). B, Tiara (Neovasc Inc, Canada). C, FORTIS (Edwards Lifesciences Inc). D, Tendyne (Abbott Inc). E, Intrepid (Medtronic Inc). F, Caisson (LivaNova, UK). G, HighLife Bioprosthesis and Subannular Implant (HighLife SAS, France). H, SAPIEN M3 (Edwards Lifesciences Inc). I, Cardiovalve (Cardiovalve, Israel). J, NaviGate (NaviGate Cardiac Structures, Inc, CA).
See this image and copyright information in PMC

References

    1. Regueiro A, Granada JF, Dagenais F, Rodés‐Cabau J. Transcatheter mitral valve replacement: insights from early clinical experience and future challenges. J Am Coll Cardiol. 2017;69:2175–2192. - PubMed
    1. Leon MB, Smith CR, Mack M, Miller DC, Moses JW, Svensson LG, Tuzcu EM, Webb JG, Fontana GP, Makkar RR, Brown DL, Block PC, Guyton RA, Pichard AD, Bavaria JE, Herrmann HC, Douglas PS, Petersen JL, Akin JJ, Anderson WN, Wang D, Pocock S; PARTNER Trial Investigators . Transcatheter aortic‐valve implantation for aortic stenosis in patients who cannot undergo surgery. N Engl J Med. 2010;363:1597–1607. - PubMed
    1. Baumgartner H, Falk V, Bax JJ, De Bonis M, Hamm C, Holm PJ, Iung B, Lancellotti P, Lansac E, Muñoz DR, Rosenhek R, Sjögren J, Mas PT, Vahanian A, Walther T, Wendler O, Windecker S, Zamorano JL. 2017 ESC/EACTS guidelines for the management of valvular heart disease. Eur Heart J. 2017;38:2739–2786. - PubMed
    1. Nkomo VT, Gardin JM, Skelton TN, Gottdiener JS, Scott CG, Enriquez‐Sarano M. Burden of valvular heart diseases: a population‐based study. Lancet. 2006;368:1005–1011. - PubMed
    1. Coffey S, Cairns BJ, Iung B. The modern epidemiology of heart valve disease. Heart. 2016;102:75–85. - PubMed

MeSH terms

LinkOut - more resources